{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:57:10Z","timestamp":1769090230154,"version":"3.49.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"India Ministry of Science & Technology Department of Biotechnology","doi-asserted-by":"publisher","award":["BT \/INF\/22\/SP41398\/2021"],"award-info":[{"award-number":["BT \/INF\/22\/SP41398\/2021"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.heliyon.2025.e41839","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T02:55:02Z","timestamp":1736477702000},"page":"e41839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anticancer activity of Ilex khasiana, a rare and endemic species of holly in Northeast India, against murine lymphoma"],"prefix":"10.1016","volume":"11","author":[{"given":"Charles","family":"Lalnunfela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawi Bawitlung","family":"Lalthanpuii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hmar Tlawmte","family":"Lalremsanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Zothansiama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chhaihlo","family":"Lalmuansangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Zosangzuali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nachimuthu Senthil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tochhawng","family":"Lalhriatpuii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9135-2703","authenticated-orcid":false,"given":"Kholhring","family":"Lalchhandama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.heliyon.2025.e41839_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.heliyon.2025.e41839_bib2","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.7150\/jca.92844","article-title":"Revisiting \u2018hallmarks of cancer\u2019 in sarcomas","volume":"15","author":"Honoki","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.heliyon.2025.e41839_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114643","article-title":"Overcoming cancer multi-drug resistance (MDR): reasons, mechanisms, nanotherapeutic solutions, and challenges","volume":"162","author":"Duan","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.heliyon.2025.e41839_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41569-020-0347-2","article-title":"Vascular toxic effects of cancer therapies","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.heliyon.2025.e41839_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100682","article-title":"Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors","volume":"50","author":"Dallavalle","year":"2020","journal-title":"Drug Resist. Updates"},{"issue":"2","key":"10.1016\/j.heliyon.2025.e41839_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/ph14020157","article-title":"Status and challenges of plant-anticancer compounds in cancer treatment","volume":"14","author":"Garcia-Oliveira","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"17","key":"10.1016\/j.heliyon.2025.e41839_bib7","doi-asserted-by":"crossref","first-page":"8605","DOI":"10.1080\/07391102.2022.2134212","article-title":"Natural product inspired leads in the discovery of anticancer agents: an update","volume":"41","author":"Sofi","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.heliyon.2025.e41839_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11658-021-00301-9","article-title":"The role of polyphenols in overcoming cancer drug resistance: a comprehensive review","volume":"27","author":"Maleki Dana","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"7","key":"10.1016\/j.heliyon.2025.e41839_bib9","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1039\/D3NP00017F","article-title":"From plant to cancer drug: lessons learned from the discovery of taxol","volume":"40","author":"Cech","year":"2023","journal-title":"Nat. Prod. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e41839_bib10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/f13010094","article-title":"Utilization of the hollies (Ilex L. spp.): a review","volume":"13","author":"Yao","year":"2022","journal-title":"Forests"},{"issue":"1","key":"10.1016\/j.heliyon.2025.e41839_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.apsb.2012.12.008","article-title":"Research progress in the phytochemistry and biology of Ilex pharmaceutical resources","volume":"3","author":"Hao","year":"2013","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.heliyon.2025.e41839_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112147","article-title":"Botany, traditional uses, phytochemistry, pharmacology and toxicology of Ilex pubescens Hook et Arn","volume":"245","author":"Jiang","year":"2019","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2025.e41839_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3724\/SP.J.1009.2010.00253","article-title":"Two triterpenoid saponins with anti-tumor activities on HepG2 and other compounds from Ilex pubescens","volume":"8","author":"Zhang","year":"2010","journal-title":"Chin. J. Nat. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2025.e41839_bib14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1248\/bpb.31.643","article-title":"In vivo anti-inflammatory and analgesic activities of a purified saponin fraction derived from the root of Ilex pubescens","volume":"31","author":"Wang","year":"2008","journal-title":"Biol. Pharm. Bull."},{"issue":"9","key":"10.1016\/j.heliyon.2025.e41839_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1055\/s-0042-123708","article-title":"Triterpenoids with antiplatelet aggregation activity from the roots of Ilex pubescens","volume":"83","author":"Tan","year":"2017","journal-title":"Planta Med."},{"key":"10.1016\/j.heliyon.2025.e41839_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112680","article-title":"Ethanol extracts from Ilex pubescens promotes cerebral ischemic tolerance via modulation of TLR4-MyD88\/TRIF signaling pathway in rats","volume":"256","author":"Fang","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.heliyon.2025.e41839_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jep.2010.06.032","article-title":"Recent advances on Ilex paraguariensis research: minireview","volume":"136","author":"Bracesco","year":"2011","journal-title":"J. Ethnopharmacol."},{"issue":"6","key":"10.1016\/j.heliyon.2025.e41839_bib18","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1021\/jf048158g","article-title":"Effect of yerba mate (Ilex paraguariensis) tea on topoisomerase inhibition and oral carcinoma cell proliferation","volume":"53","author":"Gonzalez de Mejia","year":"2005","journal-title":"J. Agric. Food Chem."},{"issue":"10","key":"10.1016\/j.heliyon.2025.e41839_bib19","first-page":"499","article-title":"Anti-proliferative activity of yerba mate (Ilex paraguariensis) aqueous extracts on human colorectal cancer cell lines, Func","volume":"11","author":"Saleh","year":"2021","journal-title":"Food Health Dis."},{"key":"10.1016\/j.heliyon.2025.e41839_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ecoleng.2011.12.004","article-title":"Habitat distribution modelling for reintroduction of Ilex khasiana Purk., a critically endangered tree species of northeastern India","volume":"40","author":"Adhikari","year":"2012","journal-title":"Ecol. Eng."},{"key":"10.1016\/j.heliyon.2025.e41839_bib21","series-title":"Forrester's Field Guide. P. Zakhuma","first-page":"60","author":"Sawmliana","year":"1998"},{"key":"10.1016\/j.heliyon.2025.e41839_bib22","series-title":"The Book of Mizoram Plants, P. Zakhuma","first-page":"142","author":"Sawmliana","year":"2003"},{"issue":"4","key":"10.1016\/j.heliyon.2025.e41839_bib23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.18311\/jnr\/2019\/23671","article-title":"Unveiling the unexplored and critically endangered Ilex khasiana for its antioxidant properties","volume":"19","author":"Lalnunfela","year":"2019","journal-title":"J. Nat. Remedies"},{"issue":"4","key":"10.1016\/j.heliyon.2025.e41839_bib24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5530\/pj.2020.12.105","article-title":"An endangered medicinal plant, Ilex khasiana exhibits potent antiparasitic activity against intestinal tapeworm","volume":"12","author":"Lalnunfela","year":"2020","journal-title":"Pharmacogn. J."},{"key":"10.1016\/j.heliyon.2025.e41839_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.17485\/IJST\/v16sp1.msc6","article-title":"In vivo evaluation of Ilex khasiana for its analgesic and anti-inflammatory activity on Swiss albino mice model","volume":"16","author":"Lalnunfela","year":"2023","journal-title":"Indian J. Sci. Technol."},{"key":"10.1016\/j.heliyon.2025.e41839_bib26","series-title":"Test No. 420: Acute Oral Toxicity - Fixed Dose Procedure, OECD Guidelines for the Testing of Chemicals, Section 4","first-page":"1","year":"2002"},{"issue":"18","key":"10.1016\/j.heliyon.2025.e41839_bib27","first-page":"4845","article-title":"Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue","volume":"51","author":"Bissery","year":"1991","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.heliyon.2025.e41839_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117232","article-title":"Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL\/6J mouse model","volume":"10","author":"Overmyer","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.heliyon.2025.e41839_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e41839_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0003-2697(76)90323-7","article-title":"Enzymatic assay for glutathione","volume":"74","author":"Brehe","year":"1976","journal-title":"Anal. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2025.e41839_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0009-8981(02)00329-7","article-title":"Rapid spectrophotometric method for serum glutathione S-transferases activity","volume":"326","author":"Habdous","year":"2002","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.heliyon.2025.e41839_bib32","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0300-9084(75)80147-7","article-title":"Enzymatic and non-enzymatic assay of superoxide dismutase","volume":"57","author":"Fried","year":"1975","journal-title":"Biochimie"},{"key":"10.1016\/j.heliyon.2025.e41839_bib33","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0076-6879(78)52032-6","article-title":"Microsomal lipid peroxidation","volume":"52","author":"Buege","year":"1978","journal-title":"Methods Enzymol."},{"issue":"6","key":"10.1016\/j.heliyon.2025.e41839_bib34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/09553009514550771","article-title":"The comet moment as a measure of DNA damage in the comet assay","volume":"67","author":"Kent","year":"1995","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.heliyon.2025.e41839_bib35","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.1194396","article-title":"Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists","volume":"330","author":"Wu","year":"2010","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.heliyon.2025.e41839_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33366-2","article-title":"Increasing the distance between two monomers of topoisomerase II\u03b2 under the action of antitumor agent 4 \u03b2-sulfur-(benzimidazole) 4\u2032-demethylepipodophyllotoxin","volume":"8","author":"Sun","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2025.e41839_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jmb.2012.07.014","article-title":"The structure of DNA-bound human topoisomerase II alpha: conformational mechanisms for coordinating inter-subunit interactions with DNA cleavage","volume":"424","author":"Wendorff","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.heliyon.2025.e41839_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1126\/science.1204117","article-title":"Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide","volume":"333","author":"Wu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2025.e41839_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molcel.2013.05.020","article-title":"Class I Hdacs share a common mechanism of regulation by inositol phosphates","volume":"51","author":"Millard","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.heliyon.2025.e41839_bib40","doi-asserted-by":"crossref","first-page":"26926","DOI":"10.1074\/jbc.M113.490706","article-title":"Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability","volume":"288","author":"Lauffer","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2025.e41839_bib41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature10728","article-title":"Structure of Hdac3 bound to co-repressor and inositol tetraphosphate","volume":"481","author":"Watson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2025.e41839_bib42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jmb.2009.01.041","article-title":"Dissecting specificity in the Janus kinases: the structures of JAK-specific inhibitors complexed to the JAK1 and JAK2 protein tyrosine kinase domains","volume":"387","author":"Williams","year":"2009","journal-title":"J. Mol. Biol."},{"issue":"13","key":"10.1016\/j.heliyon.2025.e41839_bib43","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1016\/j.bmcl.2013.05.007","article-title":"Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation","volume":"23","author":"Furet","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.heliyon.2025.e41839_bib44","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1021\/jm401642q","article-title":"Discovery and optimization of pyrimidone indoline amide PI3K\u03b2 inhibitors for the treatment of phosphatase and tensin homologue (PTEN)-deficient cancers","volume":"57","author":"Certal","year":"2014","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.heliyon.2025.e41839_bib45","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.molcel.2011.01.026","article-title":"Structure of lipid kinase p110\u03b2\/p85\u03b2 elucidates an unusual SH2-domain-mediated inhibitory mechanism","volume":"41","author":"Zhang","year":"2011","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.heliyon.2025.e41839_bib46","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1021\/jm300403a","article-title":"Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase \u03b3 inhibitors","volume":"55","author":"Leahy","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2025.e41839_bib47","first-page":"392","article-title":"Identification of a monoclonal antibody that targets PD-1 in a manner requiring PD-1 Asn58 glycosylation, Commun","volume":"2","author":"Wang","year":"2019","journal-title":"Biol."},{"issue":"9","key":"10.1016\/j.heliyon.2025.e41839_bib48","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.3390\/molecules27093041","article-title":"Accelerating AutoDock Vina with GPUs","volume":"27","author":"Tang","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.heliyon.2025.e41839_bib49","first-page":"291","article-title":"Toxicity studies of drugs and chemicals in animals: an overview, Bulg","volume":"20","author":"Saganuwan","year":"2017","journal-title":"J. Vet. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e41839_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/toxins12010035","article-title":"Natural sources and bioactivities of 2, 4-di-tert-butylphenol and its analogs","volume":"12","author":"Zhao","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2025.e41839_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136910","article-title":"Molecular structure and internal dynamics of the antioxidant 2, 6-di-tert-butylphenol","volume":"1296","author":"Li","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"7","key":"10.1016\/j.heliyon.2025.e41839_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/aoc.4381","article-title":"Antioxidative vs cytotoxic activities of organotin complexes bearing 2, 6\u2010di\u2010tert\u2010butylphenol moieties","volume":"32","author":"Antonenko","year":"2018","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.heliyon.2025.e41839_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131683","article-title":"Synthesis, cytotoxic and antioxidant activities of new n-substituted 3-(benzimidazol-2-yl)-chromones containing 2, 6-di-tert-butylphenol fragment","volume":"1249","author":"Shatokhin","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e41839_bib54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.mencom.2024.01.022","article-title":"RuII and RuIII complexes with 2, 6-di-tert-butylphenol ligands: synthesis, electrochemical behaviour, antioxidant properties and antiproliferative activity","volume":"34","author":"Antonets","year":"2024","journal-title":"Mendeleev Commun."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e41839_bib55","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/ph16010004","article-title":"Phytochemistry and anticancer effects of mangrove (Rhizophora mucronata Lam.) leaves and stems extract against different cancer cell lines","volume":"16","author":"Youssef","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.heliyon.2025.e41839_bib56","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s12639-021-01388-9","article-title":"GC\u2013MS screening and antiparasitic action of Putranjiva roxburghii leaves against sensitive and resistant strains of Leishmania donovani","volume":"45","author":"Keshav","year":"2021","journal-title":"J. Parasit. Dis."},{"key":"10.1016\/j.heliyon.2025.e41839_bib57","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s11947-016-1756-4","article-title":"Encapsulation of holy basil essential oil in gelatin: effects of palmitic acid in carboxymethyl cellulose emulsion coating on antioxidant and antimicrobial activities","volume":"9","author":"Ngamakeue","year":"2016","journal-title":"Food Bioprocess Technol."},{"issue":"6","key":"10.1016\/j.heliyon.2025.e41839_bib58","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/jobm.202100061","article-title":"Antibacterial activities of hexadecanoic acid methyl ester and green\u2010synthesized silver nanoparticles against multidrug\u2010resistant bacteria","volume":"61","author":"Shaaban","year":"2021","journal-title":"J. Basic Microbiol."},{"key":"10.1016\/j.heliyon.2025.e41839_bib59","article-title":"Molecular mechanism of palmitic acid and its derivatives in tumor progression","volume":"13","author":"Wang","year":"2023","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.heliyon.2025.e41839_bib60","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S2221-1691(12)60072-0","article-title":"In vivo anticancer activity of vanillin semicarbazone","volume":"2","author":"Ali","year":"2012","journal-title":"Asian Pac. J. Trop. Biomed."},{"issue":"7","key":"10.1016\/j.heliyon.2025.e41839_bib61","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1158\/1535-7163.MCT-06-0118","article-title":"Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice","volume":"5","author":"Mayer","year":"2006","journal-title":"Mol. Cancer Therapeut."},{"issue":"12","key":"10.1016\/j.heliyon.2025.e41839_bib62","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jcyt.2022.07.012","article-title":"\u03b3c cytokine-aided crosstalk between dendritic cells and natural killer cells together with doxorubicin induces a healer response in experimental lymphoma by downregulating FOXP3 and programmed cell death protein 1","volume":"24","author":"Singh","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/j.heliyon.2025.e41839_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(08)60263-X","article-title":"Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976\u20131982, and future directions","volume":"20","author":"Venditti","year":"1984","journal-title":"Adv. Pharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e41839_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.phyplu.2021.100211","article-title":"Biochemical and mitochondrial membrane potential changes relating to betulinic acid-mediated anticancer activity in murine ascites Dalton's lymphoma","volume":"2","author":"Bhaumik","year":"2022","journal-title":"Phytomed. Plus"},{"key":"10.1016\/j.heliyon.2025.e41839_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2019.102128","article-title":"Doxorubicin loaded pH responsive biodegradable ABA-type amphiphilic PEG-b-aliphatic polyketal-b-PEG block copolymer for therapy against aggressive murine lymphoma","volume":"24","author":"Hira","year":"2020","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e41839_bib66","doi-asserted-by":"crossref","DOI":"10.1515\/chem-2023-0159","article-title":"Some anticancer agents as effective glutathione S-transferase (GST) inhibitors","volume":"21","author":"G\u00f6k\u00e7e","year":"2023","journal-title":"Open Chem."},{"key":"10.1016\/j.heliyon.2025.e41839_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2021.108890","article-title":"Role of protein S-glutathionylation in cancer progression and development of resistance to anti-cancer drugs","volume":"704","author":"Pal","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.heliyon.2025.e41839_bib68","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/13813455.2018.1520891","article-title":"Superoxide dismutase: a review and a modified protocol for activities measurements in rat livers","volume":"126","author":"Campos-Shimada","year":"2020","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.heliyon.2025.e41839_bib69","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2147\/OPTH.S287747","article-title":"Serum malondialdehyde as a biomarker of oxidative stress in patients with primary ocular carcinoma: impact on response to chemotherapy","volume":"2021","author":"Maurya","year":"2021","journal-title":"Clin. Ophthalmol."},{"issue":"5","key":"10.1016\/j.heliyon.2025.e41839_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24356","article-title":"Elevated AST\/ALT ratio is associated with all\u2010cause mortality and cancer incident","volume":"36","author":"Chen","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"issue":"2","key":"10.1016\/j.heliyon.2025.e41839_bib71","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/life12020135","article-title":"Study of the anticancer potential of plant extracts using liver tumor microphysiological system","volume":"12","author":"Farooqi","year":"2022","journal-title":"Life"},{"issue":"8","key":"10.1016\/j.heliyon.2025.e41839_bib72","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41574-020-0365-5","article-title":"Creatine metabolism: energy homeostasis, immunity and cancer biology","volume":"16","author":"Kazak","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.heliyon.2025.e41839_bib73","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00726-011-0974-3","article-title":"A short review on creatine-creatine kinase system in relation to cancer and some experimental results on creatine as adjuvant in cancer therapy","volume":"42","author":"Patra","year":"2012","journal-title":"Amino Acids"},{"issue":"12","key":"10.1016\/j.heliyon.2025.e41839_bib74","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.trecan.2023.08.005","article-title":"Stress granules and hormetic adaptation of cancer","volume":"9","author":"Redding","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.heliyon.2025.e41839_bib75","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-food-062420-124437","article-title":"Hormesis mediates acquired resilience: using plant-derived chemicals to enhance health","volume":"12","author":"Calabrese","year":"2021","journal-title":"Annu. Rev. Food Sci. Technol."},{"issue":"6","key":"10.1016\/j.heliyon.2025.e41839_bib76","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.copbio.2007.09.006","article-title":"DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action","volume":"18","author":"Palchaudhuri","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.heliyon.2025.e41839_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-01006-w","article-title":"Novel targeted therapies of T cell lymphomas","volume":"13","author":"I\u017cykowska","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e41839_bib78","doi-asserted-by":"crossref","first-page":"52","DOI":"10.20892\/j.issn.2095-3941.2020.0400","article-title":"Updating targets for natural killer\/T-cell lymphoma immunotherapy","volume":"18","author":"Xue","year":"2021","journal-title":"Cancer Biol. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2025.e41839_bib79","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac051","article-title":"Improving protein-ligand docking and screening accuracies by incorporating a scoring function correction term","volume":"23","author":"Zheng","year":"2022","journal-title":"Briefings Bioinf."},{"issue":"10","key":"10.1016\/j.heliyon.2025.e41839_bib80","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1007\/s00432-022-04444-w","article-title":"CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment","volume":"149","author":"Bao","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.heliyon.2025.e41839_bib81","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/10428194.2020.1839654","article-title":"The role of PI3K inhibitors in the treatment of malignant lymphomas","volume":"62","author":"Berning","year":"2021","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.heliyon.2025.e41839_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114971","article-title":"Recent advances in PI3K\/PKB\/mTOR inhibitors as new anticancer agents","volume":"246","author":"Occhiuzzi","year":"2023","journal-title":"Eur. J. Med. Chem."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844025002191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844025002191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T22:15:37Z","timestamp":1769033737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844025002191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2405844025002191"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2025.e41839","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticancer activity of Ilex khasiana, a rare and endemic species of holly in Northeast India, against murine lymphoma","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2025.e41839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e41839"}}